ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BMRA Biomerica Inc

0.6303
-0.0302 (-4.57%)
22 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Biomerica Inc NASDAQ:BMRA NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.0302 -4.57% 0.6303 0.6303 0.661 0.6605 0.6215 0.6605 53,385 00:20:29

Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16

10/11/2023 1:19pm

GlobeNewswire Inc.


Biomerica (NASDAQ:BMRA)
Historical Stock Chart


From May 2023 to May 2024

Click Here for more Biomerica Charts.

Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th Annual Craig-Hallum Alpha Select Conference on November 16, 2023, at the Sheraton New York Times Square Hotel in New York City. Zackary Irani, Chief Executive Officer of Biomerica will be hosting meetings during the event, which consists of one-on-one and small group meetings.

About Biomerica (NASDAQ: BMRA) Biomerica, Inc. (www.biomerica.com) is a global biomedical technology company that develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians' offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. The Company's products are designed to enhance the health and well-being of people, while reducing total healthcare costs. Biomerica is primarily focused on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development.

Corporate Contact:

Zack Irani 949-645-2111 investors@biomerica.com

Source: Biomerica, Inc.

1 Year Biomerica Chart

1 Year Biomerica Chart

1 Month Biomerica Chart

1 Month Biomerica Chart

Your Recent History

Delayed Upgrade Clock